Objective: In this clinical trial, we aimed to compare three means of performing chronic hemodialysis in patients with contra-indication to systemic heparinization.
Methods: This open-label monocentric randomized « n-of-one » trial, conducted in a single tertiary care center, recruited chronic hemodialysis patients with a contra-indication to systemic heparinization for at least 3 consecutive sessions. All patients underwent hemodialysis with an AN69ST dialyzer, and were administered three alternative dialysis procedures in a random sequence: intermittent saline flushes, constant saline infusion, or pre-dialysis heparin coating of the membrane. The primary outcome was the need to interrupt the dialysis session because of clotting events due to either (i) a complete coagulation of the circuit; (ii) a partial coagulation of the circuit; (iii) a>50% rise over baseline in the venous pressure.
Results: At the end of the inclusion period (May, 2007 to December, 2008), the number of patients to include (n=75) was not reached: only 46 patients were included and underwent randomization. The study was terminated, and statistical analysis took into account 224 hemodialysis sessions performed in 44 patients with analyzable data. Heparin adsorption was associated with a significant reduction of the need to interrupt the dialysis session because of clotting events: odds ratio 0.3 (CI 95% 0.2 to 0.6; p<0.001, versus intermittent saline flushes). Heparin adsorption was also associated with higher odds for performing >3 h dialysis sessions and for having complete blood restitution. There were no significant effects of the dialysis procedure on weight loss, online ionic dialysance, and adverse events.
Conclusion: Heparin-coated AN69ST dialysis membrane is a safe and effective method to avoid or delay per-dialytic clotting events in patients with contra-indication to systemic anticoagulation. However, results are not generalizable safely to patients with active bleeding, since weak heparinemia, not assessed in this study, may occur.
Trial Registration: ClinicalTrials.gov NCT00473109.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019548 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097187 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Challenges of laparoscopic radical nephrectomy at the upper limits of obesity.
Urol Case Rep
November 2024
Lingard Private Hospital, 23 Merewether Street, Merewether, 2291, Newcastle, NSW, Australia.
As worldwide obesity rates increase the number of patients with an elevated BMI requiring urological surgery will increase. Although obesity has previously been considered a relative contra-indication to laparoscopic surgery, here we present a case of successful laparoscopic nephrectomy performed due to renal cancer in a patient with a BMI >60 kg/m together with a review of the associated challenges.
View Article and Find Full Text PDFOutcome of Solid Organ Transplantation in Patients With Intellectual Disability: A Systematic Literature Review.
Transpl Int
November 2024
Erasmus Medical Center (MC) Transplant Institute, Department of Surgery, Erasmus Medical Center (MC), Rotterdam, Netherlands.
Access to solid organ transplantation in patients with intellectual disability is associated with health inequities due to concerns about treatment adherence, survival rates, and post-transplant quality of life. This systematic literature review aims to compare outcomes after organ transplantation in patients with intellectual disability compared to patients without intellectual disability. Embase, Medline Ovid, PsycINFO, Web of Science, Cochrane Central Register of Trials, and Google Scholar databases were systematically searched for studies concerning pediatric or adult solid organ transplantation in recipients with a diagnosis of intellectual disability prior to transplantation.
View Article and Find Full Text PDFWhen is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
Br J Haematol
December 2024
Internal Medicine Department, Centre National de Référence des Cytopénies Auto-Immunes de l'Adulte, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil (UPEC), Créteil, France.
Article Synopsis
- Intravenous immunoglobulin (IVIg) is a preferred treatment for severe immune thrombocytopaenia (ITP), but its high cost and limited availability led to specific French guidelines on its use.
- A study assessed IVIg prescribing practices in real-life situations, evaluating compliance with these French guidelines in a sample of 114 hospitalized patients from 2016 to 2020.
- Findings showed that 84.4% of IVIg prescriptions were compliant with guidelines, and the use was notably more frequent among younger patients, with factors like corticosteroid resistance and need for surgical preparation influencing non-compliance.
Impact of the transpulmonary pressure on right ventricle impairment incidence during acute respiratory distress syndrome: a pilot study in adults and children.
Intensive Care Med Exp
September 2024
Medical Intensive Care Unit, Ambroise Paré Hospital, APHP, Boulogne, France.
Background: Right ventricle impairment (RVI) is common during acute respiratory distress syndrome (ARDS) in adults and children, possibly mediated by the level of transpulmonary pressure (P). We sought to investigate the impact of the level of P on ARDS-associated right ventricle impairment (RVI).
Methods: Adults and children (> 72 h of life) were included in this two centers prospective study if they were ventilated for a new-onset ARDS or pediatric ARDS, without spontaneous breathing and contra-indication to esophageal catheter.
How safe is lung transplantation in patients of 65 years or older? A single-center retrospective cohort.
Respir Med Res
November 2024
APHP.Nord-Université Paris Cité, Hôpital Bichat-Claude Bernard, Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, 46 rue Henri Huchard, 75018, Paris, France; Physiopathology and Epidemiology of Respiratory Diseases, UMR1152 INSERM and Université Paris Cité, 16 rue Henri Huchard, 75018, Paris, France.
Article Synopsis
- The study examines lung transplantation (LT) outcomes in patients aged 65 and older compared to younger recipients, emphasizing that age shouldn't be a strict barrier for the procedure.
- Researchers conducted a retrospective analysis of patients who underwent LT at Bichat Hospital, tracking 90-day mortality and other long-term health markers.
- Results showed that while elderly patients had better short-term lung function post-transplant, their overall survival rates and mortality within the first year were similar to those of younger patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!